Welcome to another insightful episode of the Oncology Brothers podcast! In this episode, hosts Rahul and Rohit Gosain are joined by Dr. Sam Klempner, a medical oncologist specializing in upper GI malignancies. Together, they delve into the current treatment strategies for esophageal, GE junction, and gastric adenocarcinoma.
The discussion covers a range of topics, including the evolving paradigms in neoadjuvant and adjuvant therapies, the importance of biomarker testing such as MSI and PD-L1, and the potential impact of new targets like Claudin 18.2 in upper GI cancers. Dr. Klempner also shares insights on the management of metastatic disease, including the role of targeted therapies like TDXD and Zolbetuximab.
Whether you’re a healthcare professional or simply interested in the latest advancements in oncology, this episode provides valuable information on the current landscape of upper GI malignancies. Stay informed and join the Oncology Brothers as they navigate the complexities of treating these challenging cancers. Don’t miss out on this informative discussion!
Tune in to the Oncology Brothers podcast for more expert insights and discussions on oncology topics. Remember to like, share, and subscribe for more content on the latest developments in cancer care. Thank you for listening!
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at info@oncbrothers.com
![Lowcountry hospital promotes early lung screenings for Lung Cancer Action Week [Video]](https://crowd-funding.givetaxfree.org/wp-content/uploads/2024/05/mp_261532_0_NNYN6QH7MVC4HNO7TJHBCYZEMMpng.jpg)
![Brooklyn Mourns Paul Auster Speakeasy News [Video]](https://crowd-funding.givetaxfree.org/wp-content/uploads/2024/05/mp_261606_0_SNPaulAuster24homepng.png)
